» Articles » PMID: 17640961

The Role of Complement in Inflammatory Diseases from Behind the Scenes into the Spotlight

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2007 Jul 21
PMID 17640961
Citations 294
Authors
Affiliations
Soon will be listed here.
Abstract

Our understanding of the biology of the complement system has undergone a drastic metamorphosis since its original discovery. This system, which was traditionally primarily described as a "complement" to humoral immunity, is now perceived as a central constituent of innate immunity, defending the host against pathogens, coordinating various events during inflammation, and bridging innate and adaptive immune responses. Complement is an assembly of proteins found in the blood and body fluids and on cell surfaces. Soluble complement components form the proteolytic cascade, whose activation leads to the generation of complement effectors that target various cells involved in the immune response. Membrane-bound receptors and regulators transmit signals from complement effectors to target cells and limit complement activation to the surfaces of pathogens and damaged or activated host cells. The multiple interconnections among complement proteins, immune cells, and mediators provide an excellent mechanism to protect the organism against infections and support the repair of damaged tissues. However, disturbances in this "defense machinery" contribute to the pathogenesis of various diseases. The role of complement in various inflammatory disorders is multifaceted; for example, the activation of complement can significantly contribute to inflammation-mediated tissue damage, whereas inherited or acquired complement deficiencies highly favor the development of autoimmunity.

Citing Articles

Exploring the CD3/CD56/TNF-α/Caspase3 pathway in pyrethroid-induced immune dysregulation: curcumin-loaded chitosan nanoparticle intervention.

Alsubaie N, Abd-Elhakim Y, Mohamed A, Khamis T, Metwally M, Helmi N Front Pharmacol. 2025; 16:1505432.

PMID: 39981186 PMC: 11840570. DOI: 10.3389/fphar.2025.1505432.


Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera.

Hickey T, Mudunuri U, Hempel H, Kemp T, Roche N, Talsania K Front Immunol. 2025; 15:1502458.

PMID: 39931577 PMC: 11808009. DOI: 10.3389/fimmu.2024.1502458.


SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development.

Angius F, Puxeddu S, Zaimi S, Canton S, Nematollahzadeh S, Pibiri A Vaccines (Basel). 2025; 13(1).

PMID: 39852796 PMC: 11769326. DOI: 10.3390/vaccines13010017.


Complement 3a receptor 1 on macrophages and Kupffer cells is not required for the pathogenesis of metabolic dysfunction-associated steatotic liver disease.

Homan E, Gilani A, Rubio-Navarro A, Johnson M, Schaepkens O, Cortada E Elife. 2025; 13.

PMID: 39773465 PMC: 11709426. DOI: 10.7554/eLife.100708.


Complement Immune System in Pulmonary Hypertension-Cooperating Roles of Circadian Rhythmicity in Complement-Mediated Vascular Pathology.

DeVaughn H, Rich H, Shadid A, Vaidya P, Doursout M, Shivshankar P Int J Mol Sci. 2024; 25(23).

PMID: 39684535 PMC: 11641342. DOI: 10.3390/ijms252312823.


References
1.
Davies E, Snowden N, Hillarby M, Carthy D, Grennan D, Thomson W . Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum. 1995; 38(1):110-4. DOI: 10.1002/art.1780380117. View

2.
Beutler B . TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med. 1995; 43(3):227-35. View

3.
Mulligan M, Schmid E, Beck-Schimmer B, Till G, Friedl H, Brauer R . Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest. 1996; 98(2):503-12. PMC: 507456. DOI: 10.1172/JCI118818. View

4.
Korb L, Ahearn J . C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol. 1997; 158(10):4525-8. View

5.
Botto M, DellAgnola C, Bygrave A, Thompson E, Cook H, Petry F . Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet. 1998; 19(1):56-9. DOI: 10.1038/ng0598-56. View